Patients With Autoimmune Diseases Need Boosters to Prevent COVID-19 Hospitalisation
A new study shows that even during the Omicron era, patients with systemic autoimmune rheumatic diseases face significant risks of hospitalisation due to COVID-19, particularly if unvaccinated or on immunosuppressive therapies.